Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma

Background: Cell proliferation and migration are the determinants of malignant tumor progression, and a better understanding of related genes will lead to the identification of new targets aimed at preventing the spread of cancer. Some studies have shown that KIAA1199 (CEMIP) is a transmembrane prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Xiangyu, Wang, Wei, Ma, Yunlong, Zeng, Yijia, Dou, Dandan, Fan, Haoning, Song, Jianping, Yu, Xin, Xin, Danqing, Du, Gang, Jiang, Zhengchen, Zhang, Hao, Zhang, Xinlu, Jin, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762501/
https://www.ncbi.nlm.nih.gov/pubmed/33197891
http://dx.doi.org/10.18632/aging.103964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7762501/
https://www.ncbi.nlm.nih.gov/pubmed/33197891
http://dx.doi.org/10.18632/aging.103964

Ejemplares similares